Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 215

    Bengaluru: Mylan Hackathon 2018 Winners announced

    Bengaluru: Mylan Hackathon 2018 Winners announced

    Medical Dialogues Bureau18 Oct 2018 11:18 AM IST
    BENGALURU: Mylan Pharmaceuticals Private Limited announced the winners of its second edition of the Mylan Hackathon held in Bengaluru. The two-day...
    Dr Reddy donates Rs 25 lakhs to Kerala CM distress Relief fund

    Dr Reddy donates Rs 25 lakhs to Kerala CM distress Relief fund

    Medical Dialogues Bureau18 Oct 2018 9:21 AM IST
    Hyderabad: Telangana-based pharmaceutical company, Dr Reddy’s Laboratories Ltd has donated Rs 25 lakhs to the Kerala Chief Minister Distress Relief...
    Cost of blood pressure drug surges in U.S. after recall

    Cost of blood pressure drug surges in U.S. after recall

    Medical Dialogues Bureau18 Oct 2018 9:20 AM IST
    NEW YORK (Reuters) - Prices for two dosages of the blood pressure drug valsartan rose more than any other drug in the United States in September,...
    Sanofi, Regeneron say late-stage Dupixent trials show positive results in Asthma Treatment

    Sanofi, Regeneron say late-stage Dupixent trials show positive results in Asthma Treatment

    Medical Dialogues Bureau18 Oct 2018 9:14 AM IST
    PARIS, (Reuters) - Drugmakers Sanofi and Regeneron said on Tuesday that they received positive results for their Dupixent product, which treats eczema...
    Sanofi, Novo Nordisk Eli Lilly accused of deceptive drug pricing of Insulin

    Sanofi, Novo Nordisk Eli Lilly accused of deceptive drug pricing of Insulin

    Medical Dialogues Bureau17 Oct 2018 3:16 PM IST
    US : Minnesota's attorney general on Tuesday filed a lawsuit accusing drug manufacturers Sanofi SA, Novo Nordisk and Eli Lilly and Co of deceptively...
    Alembic Pharma gets USFDA nod for diabetes drug

    Alembic Pharma gets USFDA nod for diabetes drug

    Medical Dialogues Bureau17 Oct 2018 3:16 PM IST
    Drug firm Alembic Pharmaceuticals on Tuesday said it has received a tentative nod from the US health regulator for its Alogliptin tablets used for the...
    China fines pharma firm $1.3 billion in vaccine scandal

    China fines pharma firm $1.3 billion in vaccine scandal

    Medical Dialogues Bureau17 Oct 2018 3:03 PM IST
    BEIJING: Chinese authorities have slapped penalties totaling a whopping US$1.3 billion on a pharmaceutical company over a vaccine scandal that fuelled...
    Johnson & Johnson profit beats, lifts forecast on cancer drug demand

    Johnson & Johnson profit beats, lifts forecast on cancer drug demand

    Medical Dialogues Bureau17 Oct 2018 9:10 AM IST
    Johnson & Johnson reported slightly better-than-expected third quarter profit and raised its full-year forecast on Tuesday as increased demand for...
    Sanofi, Regeneron say late-stage Dupixent trials show positive results

    Sanofi, Regeneron say late-stage Dupixent trials show positive results

    Medical Dialogues Bureau16 Oct 2018 1:56 PM IST
    PARIS: Drugmakers Sanofi and Regeneron said on Tuesday that they received positive results for their Dupixent product, which treats eczema and is seen...
    Dr Reddys finalises deal to sell Hyderabad API unit to Therapiva

    Dr Reddy's finalises deal to sell Hyderabad API unit to Therapiva

    Medical Dialogues Bureau16 Oct 2018 1:46 PM IST
    New Delhi: Drug major Dr Reddy's Laboratories (DRL) Monday said it will sell its active pharmaceutical ingredient (API) business unit in Hyderabad to...
    Lupin gets USFDA nod to market antipsychotic drug

    Lupin gets USFDA nod to market antipsychotic drug

    Garima16 Oct 2018 9:16 AM IST
    New Delhi: Drug firm Lupin Monday said it has received tentative nod from the US health regulator to market its antipsychotic Lurasidone Hydrochloride...
    Novo Nordisk picks AstraZeneca executive to head biopharma business

    Novo Nordisk picks AstraZeneca executive to head biopharma business

    Medical Dialogues Bureau16 Oct 2018 9:00 AM IST
    COPENHAGEN: Novo Nordisk has hired AstraZeneca's head of cardiovascular and metabolic diseases to head its biopharma business, which has been...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Solara Puducherry and Mangalore facilities complete USFDA Inspection with zero 483s observations

    Solara Puducherry and Mangalore facilities complete USFDA Inspection with zero 483s observations

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Ayurvedic drugs- Power up capsules, Tiger king cream found laced with Viagra, Anaesthetic: FDA

    Ayurvedic drugs- Power up capsules, Tiger king cream found laced with Viagra, Anaesthetic: FDA

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok